Khiron the only LP with a 2019 quota that authorizes the Company to manufacture high-THC whole plant extract and produce customized medical cannabis prescriptions for domestic use 56.5 tons, or 21.84% of global supply of high THC medical cannabis for commercial and scientific purposes...
from PR Newswire: https://ift.tt/2QAbsTc
No comments:
Post a Comment